Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 6, 2025
Product Development

Telix’s end-to-end radiopharma ambitions

With a NASDAQ listing, diagnostic revenues, and clinical therapeutics, logistics-forward company aims to own entire disease journey
BioCentury | Apr 22, 2019
Distillery Therapeutics

Inhibiting the LLGL2-SLC7A5-YKT6 complex for breast cancer

BioCentury | Jun 2, 2018
Product Development

Breaking from the herd

New advances in PD-1 combinations, sarcoma treatments and nucleotides at ASCO
BioCentury | Jan 17, 2018
Distillery Therapeutics

Cancer

BioCentury | Feb 3, 2017
Company News

Therapeia, Telix deal

BioCentury | Jun 23, 2016
Distillery Therapeutics

Therapeutics: Solute carrier family 7 member 5 (SLC7A5; LAT1)

Items per page:
1 - 6 of 6